Efficacy of idelalisib in Cll subpopulations harboring del(17p) and other adverse prognostic factors: Results from a phase 3, randomized, double-blind, placebo-controlled trial Meeting Abstract
| Authors: | Stilgenbauer, S.; Coutre, S. E.; Furman, R. R.; Cheson, B. D.; Pagel, J. M.; Hillmen, P.; Barrientos, J. C.; Zelenetz, A. D.; Kipps, T. J.; Flinn, I. W.; Ghia, P.; Hallek, M. J.; Coiffier, B.; O'Brien, S. M.; Tausch, E.; Kreuzer, K. A.; Jiang, W.; Jahn, T. M.; Lazarov, M.; Sharman, J. P. |
| Abstract Title: | Efficacy of idelalisib in Cll subpopulations harboring del(17p) and other adverse prognostic factors: Results from a phase 3, randomized, double-blind, placebo-controlled trial |
| Meeting Title: | 19th Congress of the European Hematology Association (EHA) |
| Journal Title: | Haematologica |
| Volume: | 99 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2014 Jun 12-15 |
| Meeting Location: | Milan, Italy |
| ISSN: | 0390-6078 |
| Publisher: | Ferrata Storti Foundation |
| Date Published: | 2014-06-01 |
| Start Page: | 521 |
| Language: | English |
| ACCESSION: | WOS:000342830902325 |
| PROVIDER: | wos |
| PMCID: | PMC4060398 |
| Notes: | Meeting Abstract: S1341 -- 19th Congress of the European-Hematology-Association -- JUN 12-15, 2014 -- Milan, ITALY -- Source: Wos |
MSK Authors
-
767Zelenetz